-
1181por Satzke, Catherine, Dunne, Eileen M., Porter, Barbara D., Klugman, Keith P., Mulholland, E. Kim“…Understanding pneumococcal carriage is essential for evaluating the impact of pneumococcal vaccines. Traditional serotyping methods are cumbersome and insufficient for detecting multiple serotype carriage, and there are few data comparing the new methods that have been developed over the past decade. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1182por Stacevičienė, Indrė, Petraitienė, Sigita, Vaičiūnienė, Daiva, Alasevičius, Tomas, Kirslienė, Jūratė, Usonis, Vytautas“…We evaluated the circulation of SPn serotypes and antimicrobial susceptibility among preschool children in Lithuania before the introduction of universal infant pneumococcal vaccination. METHODS: A prospective study was carried out from February 2012 to March 2013 in five cities of Lithuania. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1183por Mohale, Thabo, Wolter, Nicole, Allam, Mushal, Ndlangisa, Kedibone, Crowther-Gibson, Penny, du Plessis, Mignon, von Gottberg, Anne“…BACKGROUND: The capsular polysaccharide is the principal virulence factor of Streptococcus pneumoniae and a target for current pneumococcal vaccines. However, some pathogenic pneumococci are serologically nontypeable [nontypeable pneumococci (NTPn)]. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1184por Lin, Jialing, Peng, Yang, Xu, Ping, Zhang, Ting, Bai, Chan, Lin, Dongxin, Ou, Qianting, Yao, Zhenjiang“…A number of influencing factors for MRSA nasal colonization were noted in three eligible studies: gender (male vs female; OR: 0.67; 95% CI: 0.55–0.82), younger age (OR: 2.98; 95% CI: 1.31–6.96 and OR: 1.56; 95% CI: 1.21–2.00), attending day care centers (OR: 2.97; 95% CI: 1.28–6.76), having infectious diseases (OR: 2.31; 95% CI: 1.10–4.52), using antibiotics (OR: 2.77; 95% CI: 1.45–5.05), residing in northern Taiwan (OR: 1.41; 95% CI: 1.15–1.71), passive smoking (OR: 1.30; 95% CI: 1.02–1.63), and pneumococcal vaccination (OR: 1.22; 95% CI: 1.01–1.48). CONCLUSIONS: Children could act as reservoirs of MRSA transmissions. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1185por Ufer, Mike, Shakeri-Nejad, Kasra, Gardin, Anne, Su, Zhenzhong, Paule, Ines, Marbury, Thomas C., Legangneux, Eric“…CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in healthy persons, siponimod had limited effect on the immune response following influenza or pneumococcal vaccinations.…”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1186por Vissers, Marloes, Wijmenga-Monsuur, Alienke J., Knol, Mirjam J., Badoux, Paul, van Houten, Marlies A., van der Ende, Arie, Sanders, Elisabeth A. M., Rots, Nynke Y.“…In conclusion, 10 years after the introduction of pneumococcal vaccination in children in The Netherlands shifts in carriage and disease serotypes are still ongoing. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1187por Jayaraman, Yuvaraj, Veeraraghavan, Balaji, Chethrapilly Purushothaman, Girish Kumar, Sukumar, Bharathy, Kangusamy, Boopathi, Nair Kapoor, Ambujam, Gupta, Nivedita, Mehendale, Sanjay Madhav“…Continued surveillance is expected to provide valuable information and trends in future, to take an informed decision on introduction of pneumococcal vaccination in Universal Immunization Programme in India and will also eventually help in post-vaccination impact evaluation.…”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1188por Balsamo, Claudia, Biagi, Carlotta, Mancini, Margherita, Corsini, Ilaria, Bergamaschi, Rosalba, Lanari, Marcello“…CONCLUSIONS: Despite the introduction of pneumococcal vaccines, the incidence of acute mastoiditis in our population has not been reduced during the last years. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1189“…BACKGROUND: Despite the widespread availability of pneumococcal vaccines, rates of pneumococcal disease are disproportionately high in adults with chronic and immunocompromising conditions. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1190por McLaughlin, John M., Swerdlow, David L., Khan, Farid, Will, Oliver, Curry, Aaron, Snow, Vincenza, Isturiz, Raul E., Jodar, Luis“…In order to maximize the benefits of pneumococcal vaccination, further targeted and tailored interventions to increase PCV13 uptake in these underserved populations are still necessary.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1191por Tanaka, Mizuki, Hasegawa, Shiori, Nakao, Satoshi, Shimada, Kazuyo, Mukai, Ririka, Matsumoto, Kiyoka, Nakamura, Mitsuhiro“…The median durations (interquartile range) for DIHL due to platinum compounds, sulfonamides (plain), interferons, antivirals for treatment of hepatitis C virus (HCV) infections, other aminoglycosides, carboxamide derivatives, macrolides, and pneumococcal vaccines were 25.5 (7.5–111.3), 80.5 (4.5–143.0), 64.0 (14.0–132.0), 53.0 (9.0–121.0), 11.0 (3.0–26.8), 1.5 (0.3–11.5), 3.5 (1.3–6.8), and 2.0 (1.0–4.5), respectively. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1192“…Index drugs other than amoxicillin, cardiovascular disease, pneumococcal vaccination and more primary care consultations were statistically significantly associated with repeat prescriptions for LRTI (p<0.05). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1193por Wouters, Ine, Desmet, Stefanie, Van Heirstraeten, Liesbet, Herzog, Sereina A, Beutels, Philippe, Verhaegen, Jan, Goossens, Herman, Van Damme, Pierre, Malhotra-Kumar, Surbhi, Theeten, Heidi“…These results complement invasive pneumococcal disease surveillance data, providing further basis for pneumococcal vaccination programme policy making.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1194por Kouni, S., Karakitsos, P., Chranioti, A., Theodoridou, M., Chrousos, G., Michos, A.“…Multiple logistic regression analysis revealed that viral co‐infections were associated with increased probability for hospitalization (OR 1.52, 95% CI 1.01–2.29, p 0.04), and previous pneumococcal vaccination was associated with decreased probability for hospitalization (OR 0.52, 95% CI 0.33–0.81, p 0.004). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1195por Boelsen, Laura K., Dunne, Eileen M., Gould, Katherine A., Ratu, F. Tupou, Vidal, Jorge E., Russell, Fiona M., Mulholland, E. Kim, Hinds, Jason, Satzke, Catherine“…Streptococcus pneumoniae (the pneumococcus) carriage is commonly used to measure effects of pneumococcal vaccines. Based on findings from culture-based studies, the World Health Organization recommends both nasopharyngeal (NP) and oropharyngeal (OP) sampling for detecting adult carriage. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1196por Kurbatova, Ekaterina A., Akhmatova, Nelli K., Zaytsev, Anton E., Akhmatova, Elina A., Egorova, Nadezhda B., Yastrebova, Natalya E., Sukhova, Elena V., Yashunsky, Dmitriy V., Tsvetkov, Yury E., Nifantiev, Nikolay E.“…Synthetic oligosaccharides (OSs) may provide an alternative to CPs for development of novel conjugated pneumococcal vaccines and diagnostic test systems. A comparative immunological study of di–, tri–, and tetra–bovine serum albumin (BSA) conjugates was performed. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1197por Uddén, Fabian, Ahl, Jonas, Littorin, Nils, Strålin, Kristoffer, Athlin, Simon, Riesbeck, Kristian“…IMPORTANCE Numerous reports on the dynamics of antipneumococcal immunity in relation to immunization with pneumococcal vaccines and on the prevalence of naturally acquired immunity in various populations have been published. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1198por Swarthout, Todd D., Gori, Andrea, Bar-Zeev, Naor, Kamng’ona, Arox W., Mwalukomo, Thandie S., Bonomali, Farouck, Nyirenda, Roseline, Brown, Comfort, Msefula, Jacquline, Everett, Dean, Mwansambo, Charles, Gould, Katherine, Hinds, Jason, Heyderman, Robert S., French, Neil“…Accurate assessment of the serotype distribution associated with pneumococcal colonization and disease is essential for evaluating and formulating pneumococcal vaccines and for informing vaccine policy. For this reason, we evaluated the concordance between pneumococcal serotyping results by latex agglutination, whole-genome sequencing (WGS) with PneumoCaT, and DNA microarray for samples from community carriage surveillance in Blantyre, Malawi. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1199“…BACKGROUND: Hospitalizations are an opportunity to increase vaccine uptake and hospital-based strategies have been effective at increasing influenza and pneumococcal vaccination. Offering COVID-19 vaccination at discharge can reduce barriers to vaccination and target patients at high risk for severe illness and death. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1200por Augustynowicz, Anna, Borowska, Mariola, Lewtak, Katarzyna, Borowicz, Jacek, Waszkiewicz, Michał, Karakiewicz, Beata, Opolski, Janusz, Banaś, Tomasz, Czerw, Aleksandra“…The decrease in the number of people vaccinated against pneumococci may result from including pneumococcal vaccines in the compulsory immunization schedule.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto